{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:50:14Z","timestamp":1720313414981},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/s0924-977x(16)31439-0","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T15:38:19Z","timestamp":1477928299000},"page":"S450-S451","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S2","title":["The impact of antipsychotic drugs on behaviour: new perspectives from the methylazoxymethanol rodent model of schizophrenia"],"prefix":"10.1016","volume":"26","author":[{"given":"M.","family":"Morais","sequence":"first","affiliation":[]},{"given":"J.","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"S.","family":"Aslani","sequence":"additional","affiliation":[]},{"given":"P.","family":"Patricio","sequence":"additional","affiliation":[]},{"given":"N.","family":"Alves","sequence":"additional","affiliation":[]},{"given":"J.","family":"Correia","sequence":"additional","affiliation":[]},{"given":"A.R.","family":"Machado-Santos","sequence":"additional","affiliation":[]},{"given":"A.","family":"Mateus-Pinheiro","sequence":"additional","affiliation":[]},{"given":"C.","family":"Portugal","sequence":"additional","affiliation":[]},{"given":"L.","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"J.","family":"Palha","sequence":"additional","affiliation":[]},{"given":"N.","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"J.M.","family":"Bessa","sequence":"additional","affiliation":[]}],"member":"78","container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X16314390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X16314390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T00:30:00Z","timestamp":1536280200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X16314390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":0,"alternative-id":["S0924977X16314390"],"URL":"https:\/\/doi.org\/10.1016\/s0924-977x(16)31439-0","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}